Log in

NYSEARCA:IBDMiBonds Dec 2021 Term Corporate ETF Stock Price, Forecast & News

$25.08
-0.03 (-0.12 %)
(As of 07/10/2020 04:00 PM ET)
Add
Today's Range
$25.06
Now: $25.08
$25.12
50-Day Range
$25.08
MA: $25.12
$25.15
52-Week Range
$22.15
Now: $25.08
$25.55
Volume231,000 shs
Average Volume308,967 shs
Market Capitalization$1.47 billion
P/E RatioN/A
Dividend Yield2.55%
BetaN/A

Geographic Exposure of IBDM

Currency Exposure of IBDM

Sector Exposure of IBDM

Industry Exposure of IBDM


Basic Details

Issuer iShares
Fund NameiBonds Dec 2021 Term Corporate ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IBDM
Inception Date3/10/2015
Fund ManagerJames Mauro, Scott Radell
WebN/A
PhoneN/A

Fund Focus

Asset ClassFixed Income
BenchmarkBloomberg Barclays December 2021 Maturity Corporate Index
CategoryCorporate
FocusInvestment Grade
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$1.47 billion
Average Daily Volume$254,151.60
Discount/Premium0.02%

ETF Expenses

Management Fee0.10%
Other Expenses0.00%
Total Expenses0.10%
Fee Waiver0.00%
Net Expenses0.10%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Receive IBDM News and Ratings via Email

Sign-up to receive the latest news and ratings for IBDM and its competitors with MarketBeat's FREE daily newsletter.

iBonds Dec 2021 Term Corporate ETF (NYSEARCA:IBDM) Frequently Asked Questions

How has iBonds Dec 2021 Term Corporate ETF's stock been impacted by COVID-19 (Coronavirus)?

iBonds Dec 2021 Term Corporate ETF's stock was trading at $24.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IBDM shares have increased by 0.9% and is now trading at $25.08. View which stocks have been most impacted by Coronavirus.

How often does iBonds Dec 2021 Term Corporate ETF pay dividends? What is the dividend yield for iBonds Dec 2021 Term Corporate ETF?

iBonds Dec 2021 Term Corporate ETF announced a monthly dividend on Monday, February 3rd. Shareholders of record on Tuesday, February 4th will be given a dividend of $0.0539 per share on Friday, February 7th. This represents a $0.65 annualized dividend and a yield of 2.58%. The ex-dividend date is Monday, February 3rd. This is a boost from iBonds Dec 2021 Term Corporate ETF's previous monthly dividend of $0.05. View iBonds Dec 2021 Term Corporate ETF's dividend history.

Has iBonds Dec 2021 Term Corporate ETF been receiving favorable news coverage?

News articles about IBDM stock have trended negative on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. iBonds Dec 2021 Term Corporate ETF earned a news impact score of -2.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about iBonds Dec 2021 Term Corporate ETF.

What other stocks do shareholders of iBonds Dec 2021 Term Corporate ETF own?

What is iBonds Dec 2021 Term Corporate ETF's stock symbol?

iBonds Dec 2021 Term Corporate ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IBDM."

Who are iBonds Dec 2021 Term Corporate ETF's major shareholders?

iBonds Dec 2021 Term Corporate ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (0.08%), Chesley Taft & Associates LLC (0.03%), Norway Savings Bank (0.02%) and Pinnacle Bank (0.01%).

Which major investors are selling iBonds Dec 2021 Term Corporate ETF stock?

IBDM stock was sold by a variety of institutional investors in the last quarter, including Pinnacle Bank.

Which major investors are buying iBonds Dec 2021 Term Corporate ETF stock?

IBDM stock was purchased by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Chesley Taft & Associates LLC, and Norway Savings Bank.

How do I buy shares of iBonds Dec 2021 Term Corporate ETF?

Shares of IBDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iBonds Dec 2021 Term Corporate ETF's stock price today?

One share of IBDM stock can currently be purchased for approximately $25.08.

How big of a company is iBonds Dec 2021 Term Corporate ETF?

iBonds Dec 2021 Term Corporate ETF has a market capitalization of $1.47 billion.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.